Organizational and Management Impact Analysis of Using the New Subcutaneous Formulation of Tocilizumab in Selected Italian Rheumatology Centers
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2632
https://www.valueinhealthjournal.com/article/S1098-3015(14)04581-1/fulltext
Title :
Organizational and Management Impact Analysis of Using the New Subcutaneous Formulation of Tocilizumab in Selected Italian Rheumatology Centers
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04581-1&doi=10.1016/j.jval.2014.08.2632
First page :
A383
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
332